SCHEDULE CALL
Serotonin Antagonist and Reuptake Inhibitors (SARI) Market Research Report By Drug Type (Selective Serotonin Reuptake Inhibitors, Dual-Action Serotonin Antagonists, Serotonin Norepinephrine Reuptake Inhibitors), By Indication (Depression, Anxiety Disorders, Obsessive-Compulsive Disorder), By Route of Administration (Oral, Intravenous, Intramuscular), By End Use (Hospitals, Clinics, Homecare) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2034
No. of Pages: 128
Report Code : MRFR/Pharma/37365-HCR
